• 25450 Citations
  • 75 h-Index
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robert Orlowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma

Shirazi, F., Jones, R. J., Singh, R. K., Zou, J., Kuiatse, I., Berkova, Z., Wang, H., Lee, H. C., Hong, S., Dick, L., Chattopadhyay, N. & Orlowski, R. Z., Aug 2020, In : Proceedings of the National Academy of Sciences of the United States of America. 117, 33, p. 20004-20014 11 p.

Research output: Contribution to journalArticle

  • A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

    Du, Z., Weinhold, N., Song, G. C., Rand, K. A., Van Den Berg, D. J., Hwang, A. E., Sheng, X., Hom, V., Ailawadhi, S., Nooka, A. K., Singhal, S., Pawlish, K., Peters, E. S., Bock, C., Mohrbacher, A., Stram, A., Berndt, S. I., Blot, W. J., Casey, G., Stevens, V. L. & 50 others, Kittles, R., Goodman, P. J., Diver, W. R., Hennis, A., Nemesure, B., Klein, E. A., Rybicki, B. A., Stanford, J. L., Witte, J. S., Signorello, L., John, E. M., Bernstein, L., Stroup, A. M., Stephens, O. W., Zangari, M., Van Rhee, F., Olshan, A., Zheng, W., Hu, J. J., Ziegler, R., Nyante, S. J., Ingles, S. A., Press, M. F., Carpten, J. D., Chanock, S. J., Mehta, J., Colditz, G. A., Wolf, J., Martin, T. G., Tomasson, M., Fiala, M. A., Terebelo, H., Janakiraman, N., Kolonel, L., Anderson, K. C., Le Marchand, L., Auclair, D., Chiu, B. C. H., Ziv, E., Stram, D., Vij, R., Bernal-Mizrachi, L., Morgan, G. J., Zonder, J. A., Huff, C. A., Lonial, S., Orlowski, R. Z., Conti, D. V., Haiman, C. A. & Cozen, W., Jan 14 2020, In : Blood Advances. 4, 1, p. 181-190 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial

    Kumar, S. K., Jacobus, S. J., Cohen, A. D., Weiss, M., Callander, N., Singh, A. K., Parker, T. L., Menter, A., Yang, X., Parsons, B., Kumar, P., Kapoor, P., Rosenberg, A., Zonder, J. A., Faber, E., Lonial, S., Anderson, K. C., Richardson, P. G., Orlowski, R. Z., Wagner, L. I. & 1 others, Rajkumar, S. V., Oct 2020, In : The lancet oncology. 21, 10, p. 1317-1330 14 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

    Dimopoulos, M. A., Jakubowiak, A. J., McCarthy, P. L., Orlowski, R. Z., Attal, M., Bladé, J., Goldschmidt, H., Weisel, K. C., Ramasamy, K., Zweegman, S., Spencer, A., Huang, J. S. Y., Lu, J., Sunami, K., Iida, S., Chng, W. J., Holstein, S. A., Rocci, A., Skacel, T., Labotka, R. & 2 others, Palumbo, A. & Anderson, K. C., Feb 1 2020, In : Blood cancer journal. 10, 2, 17.

    Research output: Contribution to journalReview article

    Open Access
  • 8 Scopus citations